Literature DB >> 6138603

Failure of fibronectin as an opsonin in the host defence system: a case of competitive self inhibition?

R A Brown.   

Abstract

In the course of various clinical conditions, consumption of opsonic fibronectin is thought to impair the function of the reticuloendothelial (RE) host defence system. Despite evidence to support its central role in host defence, measurements of circulating fibronectin levels appear to have limited diagnostic or prognostic value. It seems that the problem may be more complex than a simple depletion of fibronectin. It is proposed that the structure of fibronectin can allow a condition of opsonic dysfunction to arise in certain patients, irrespective of the concentration of immunoreactive fibronectin. Fibronectin fragments bound to the target particles (fibrin aggregates, tissue debris, microorganisms) would prevent the binding of fibronectin and so inhibit phagocytosis by cells of the RE system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138603     DOI: 10.1016/s0140-6736(83)91042-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Plasma fibronectin concentrations in blood products.

Authors:  J Perttilä; M Salo; O Peltola
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Changes in plasma fibronectin during allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M Bowen
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

3.  Plasma fibronectin and thyroid function.

Authors:  W Graninger; K Pirich; K Derfler; W Waldhäusl
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

4.  Childhood kidney tumours: in vitro studies and natural history.

Authors:  S Kumar; H B Marsden; M C Calabuig
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  Specific attachment of Staphylococcus aureus to immobilized fibronectin.

Authors:  I Maxe; C Rydén; T Wadström; K Rubin
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

6.  Differences between plasma and synovial fluid fibronectin.

Authors:  D L Scott; S D Carter; J S Coppock; M Robinson; K W Walton
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.